bioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) was the target of a large decrease in short interest during the month of January. As of January 15th, there was short interest totalling 118,300 shares, a decrease of 19.1% from the December 31st total of 146,200 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 1,183.0 days.

bioMérieux Stock Up 2.3 %

Shares of OTCMKTS BMXMF traded up $2.75 during trading hours on Thursday, hitting $120.00. 2,519 shares of the company’s stock were exchanged, compared to its average volume of 2,112. The company’s 50-day moving average price is $107.02 and its 200-day moving average price is $110.00. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.21 and a quick ratio of 1.20. bioMérieux has a 1-year low of $93.50 and a 1-year high of $122.52.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.